{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:51:21Z","timestamp":1792518681381,"version":"4.5.0"},"reference-count":143,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemistry and Physics of Lipids"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.chemphyslip.2026.105574","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T20:24:29Z","timestamp":1772483069000},"page":"105574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Lipid-based nanocarriers for antiviral drug delivery: A review of the advances, manufacturing technologies, therapeutic mechanisms, and clinical applications"],"prefix":"10.1016","volume":"275","author":[{"given":"Heena","family":"Maithania","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Tiwary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishil","family":"Oswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chemphyslip.2026.105574_bib1","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ejpb.2016.11.034","article-title":"Food, gastrointestinal pH, and models of oral drug absorption","volume":"112","author":"Abuhelwa","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.chemphyslip.2026.105574_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193326","article-title":"Factors determining dengue outbreak in Malaysia","volume":"13","author":"Ahmad","year":"2018","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.chemphyslip.2026.105574_bib3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1080\/10837450.2022.2084554","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers: a review of the methods of manufacture and routes of administration","volume":"27","author":"Akbari","year":"2022","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.chemphyslip.2026.105574_bib4","article-title":"The role of lipid components in lipid nanoparticles for vaccines and gene therapy","volume":"188","author":"Albertsen","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.chemphyslip.2026.105574_bib5","article-title":"Exploring the landscape of Lipid Nanoparticles (LNPs): a comprehensive review of LNPs types and biological sources of lipids","volume":"8","author":"Alfutaimani","year":"2024","journal-title":"Int. J. Pharm. X"},{"issue":"1","key":"10.1016\/j.chemphyslip.2026.105574_bib6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.chemphyslip.2026.105574_bib7","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00253-024-13114-5","article-title":"Synthesis of polymeric nanoparticles by double emulsion and pH-driven: encapsulation of antibiotics and natural products for combating Escherichia coli infections","volume":"108","author":"de Almeida Campos","year":"2024","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.chemphyslip.2026.105574_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2020.08.002","article-title":"An RNAi therapeutic, DFP-10825, for intraperitoneal and intrapleural malignant cancers","volume":"154","author":"Ando","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.chemphyslip.2026.105574_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116433","article-title":"Solid lipid nanoparticles and their application in the treatment of bacterial infectious diseases","volume":"174","author":"Arabestani","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.chemphyslip.2026.105574_bib10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.colsurfb.2014.12.014","article-title":"Formulation and development of bicontinuous nanostructured liquid crystalline particles of efavirenz","volume":"126","author":"Avachat","year":"2015","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"5","key":"10.1016\/j.chemphyslip.2026.105574_bib11","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0022-2836(64)80115-7","article-title":"Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope","volume":"8","author":"Bangham","year":"1964","journal-title":"J. Mol. Biol."},{"issue":"10","key":"10.1016\/j.chemphyslip.2026.105574_bib12","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1002\/anie.201804067","article-title":"Cubosomes: the next generation of smart lipid nanoparticles?","volume":"58","author":"Barriga","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"issue":"4","key":"10.1016\/j.chemphyslip.2026.105574_bib13","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3390\/v14040799","article-title":"Plasma membrane-derived liposomes exhibit robust antiviral activity against HSV-1","volume":"14","author":"Bhattacharya","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.chemphyslip.2026.105574_bib14","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jconrel.2024.07.021","article-title":"Rational formulation and industrial manufacturing of lipid-based complex injectables: Landmarks and trends","volume":"373","author":"Biscaia-Caleiras","year":"2024","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.chemphyslip.2026.105574_bib15","doi-asserted-by":"crossref","first-page":"taaa001","DOI":"10.1093\/jtm\/taaa001","article-title":"Zika outbreak in India in 2018","volume":"27","author":"Biswas","year":"2020","journal-title":"J. Travel Med."},{"issue":"1","key":"10.1016\/j.chemphyslip.2026.105574_bib16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13104-024-07042-w","article-title":"Real-time epidemiological surveillance data: tracking the occurrences of avian influenza outbreaks around the world","volume":"18","author":"Branda","year":"2025","journal-title":"BMC Res. Notes"},{"issue":"10\u201311","key":"10.1016\/j.chemphyslip.2026.105574_bib17","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.addr.2011.05.017","article-title":"Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles","volume":"63","author":"Cai","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.chemphyslip.2026.105574_bib18","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1006\/phrs.2000.0737","article-title":"Transmucosal transport of tobramycin incorporated in SLN after duodenal administration to rats. Part I\u2014a pharmacokinetic study","volume":"42","author":"Cavalli","year":"2000","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.chemphyslip.2026.105574_bib19","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s13346-020-00818-0","article-title":"Nanotechnology-based antiviral therapeutics","volume":"11","author":"Chakravarty","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"issue":"6","key":"10.1016\/j.chemphyslip.2026.105574_bib20","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.addr.2007.09.010","article-title":"Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective","volume":"60","author":"Chen","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.chemphyslip.2026.105574_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106688","article-title":"Recent advances and clinical translation of liposomal delivery systems in cancer therapy","volume":"193","author":"Chen","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.chemphyslip.2026.105574_bib22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ejps.2017.09.041","article-title":"A comparison study between lycobetaine-loaded nanoemulsion and liposome using nRGD as therapeutic adjuvant for lung cancer therapy","volume":"111","author":"Chen","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.chemphyslip.2026.105574_bib23","first-page":"63","article-title":"Zeta potential measurement","author":"Clogston","year":"2011","journal-title":"Charact. Nanopart. Intend. Drug Deliv."},{"issue":"1721","key":"10.1016\/j.chemphyslip.2026.105574_bib24","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2016.0297","article-title":"The Ebola outbreak, 2013\u20132016: old lessons for new epidemics","volume":"372","author":"Coltart","year":"2017","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"issue":"45","key":"10.1016\/j.chemphyslip.2026.105574_bib25","doi-asserted-by":"crossref","first-page":"26777","DOI":"10.1039\/D0RA03491F","article-title":"A brief review on solid lipid nanoparticles: Part and parcel of contemporary drug delivery systems","volume":"10","author":"Duan","year":"2020","journal-title":"RSC Adv."},{"issue":"9","key":"10.1016\/j.chemphyslip.2026.105574_bib26","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.3390\/polym15092196","article-title":"Nanoparticle-based drug delivery systems: an inspiring therapeutic strategy for neurodegenerative diseases","volume":"15","author":"Duan","year":"2023","journal-title":"Polymers"},{"key":"10.1016\/j.chemphyslip.2026.105574_bib27","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fcimb.2019.00042","article-title":"How viral and intracellular bacterial pathogens reprogram the metabolism of host cells to allow their intracellular replication","volume":"9","author":"Eisenreich","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"10.1016\/j.chemphyslip.2026.105574_bib28","first-page":"18","article-title":"Development and characterization of nanostructure lipid carrier for anti-hepatitis-C virus drug","volume":"7","author":"EL-Badry","year":"2024","journal-title":"J. Adv. Biomed. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.chemphyslip.2026.105574_bib29","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1097\/MS9.0000000000000979","article-title":"Chikungunya outbreak in Africa: a review of the literature","volume":"85","author":"Eneh","year":"2023","journal-title":"Ann. Med. Surg."},{"issue":"17","key":"10.1016\/j.chemphyslip.2026.105574_bib30","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.4155\/fmc-2016-0135","article-title":"Liposomal drug delivery systems for targeted cancer therapy: is active targeting the best choice?","volume":"8","author":"Fathi","year":"2016","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.chemphyslip.2026.105574_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2025.143785","article-title":"Boosting curcumin\u2019s chemical stability and intestinal absorption via nanostructured lipid carriers: the impact of lipid composition","volume":"479","author":"Feng","year":"2025","journal-title":"Food Chem."},{"key":"10.1016\/j.chemphyslip.2026.105574_bib32","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3389\/fchem.2018.00323","article-title":"Spectroscopic studies as a toolbox for biophysical and chemical characterization of lipid-based nanotherapeutics","volume":"6","author":"Fernandes","year":"2018","journal-title":"Front. Chem."},{"key":"10.1016\/j.chemphyslip.2026.105574_bib33","doi-asserted-by":"crossref","first-page":"6109","DOI":"10.2147\/IJN.S178077","article-title":"Microfluidization trends in the development of nanodelivery systems and applications in chronic disease treatments","author":"Ganesan","year":"2018","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.chemphyslip.2026.105574_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10611860500525370","article-title":"Reduced hematopoietic toxicity, enhanced cellular uptake and altered pharmacokinetics of azidothymidine loaded galactosylated liposomes","volume":"14","author":"Garg","year":"2006","journal-title":"J. Drug Target."},{"issue":"9","key":"10.1016\/j.chemphyslip.2026.105574_bib35","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.3390\/biomedicines10092137","article-title":"Lipid-based drug delivery systems for diseases managements","volume":"10","author":"Gbian","year":"2022","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.chemphyslip.2026.105574_bib36","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3390\/v13040667","article-title":"Broad-spectrum antiviral strategies and nucleoside analogues","volume":"13","author":"Geraghty","year":"2021","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.chemphyslip.2026.105574_bib37","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4103\/1735-5362.235156","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages","volume":"13","author":"Ghasemiyeh","year":"2018","journal-title":"Res. Pharm. Sci."},{"issue":"21","key":"10.1016\/j.chemphyslip.2026.105574_bib38","doi-asserted-by":"crossref","first-page":"6440","DOI":"10.3390\/molecules26216440","article-title":"Antiviral potential of naphthoquinones derivatives encapsulated within liposomes","volume":"26","author":"Giongo","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.chemphyslip.2026.105574_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106928","article-title":"Establishment of a semi-continuous nano-production line using the Microfluidizer\u00ae technology for the fabrication of lipid-based nanoparticles part 1: screening of critical parameters and design of experiment optimization studies","volume":"203","author":"Glader","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"issue":"18","key":"10.1016\/j.chemphyslip.2026.105574_bib40","doi-asserted-by":"crossref","first-page":"14315","DOI":"10.1039\/D5RA00746A","article-title":"Progress on liposome delivery systems in the treatment of bladder cancer","volume":"15","author":"Guo","year":"2025","journal-title":"RSC Adv."},{"key":"10.1016\/j.chemphyslip.2026.105574_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125562","article-title":"Harnessing unique architecture and emerging strategies of solid lipid nanoparticles to combat colon cancer: a state-of-the-art review","author":"Gupta","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.chemphyslip.2026.105574_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114097","article-title":"Oral delivery of therapeutic peptides and proteins: technology landscape of lipid-based nanocarriers","volume":"182","author":"Haddadzadegan","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.chemphyslip.2026.105574_bib43","doi-asserted-by":"crossref","first-page":"P7","DOI":"10.1186\/1471-2334-12-S1-P7","article-title":"Development of Efavirenz nanoparticle for enhanced efficiency of anti-retroviral therapy against HIV and AIDS","volume":"12","author":"Hari","year":"2012","journal-title":"BMC Infect. Dis."},{"issue":"12","key":"10.1016\/j.chemphyslip.2026.105574_bib44","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.chemphyslip.2026.105574_bib45","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejpb.2016.10.018","article-title":"Industrialization of lipid nanoparticles: From laboratory-scale to large-scale production line","volume":"109","author":"Hu","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.chemphyslip.2026.105574_bib46","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41392-024-01745-z","article-title":"Nanotechnology\u2019s frontier in combatting infectious and inflammatory diseases: prevention and treatment","volume":"9","author":"Huang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.chemphyslip.2026.105574_bib47","first-page":"1","article-title":"Nanotechnology approaches for antiretroviral drugs delivery","volume":"1","author":"Iannazzo","year":"2015","journal-title":"J. Aids Hiv. Infect."},{"issue":"1","key":"10.1016\/j.chemphyslip.2026.105574_bib48","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/21691401.2014.909822","article-title":"Nanostructured lipid carriers and their current application in targeted drug delivery","volume":"44","author":"Jaiswal","year":"2016","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"8","key":"10.1016\/j.chemphyslip.2026.105574_bib49","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/jphp.12737","article-title":"\u201cEncapsulation of ritonavir in solid lipid nanoparticles: in-vitro anti-HIV-1 activity using lentiviral particles,\u201d","volume":"69","author":"Javan","year":"2017","journal-title":"J. Pharm. Pharm."},{"issue":"3","key":"10.1016\/j.chemphyslip.2026.105574_bib50","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3390\/pharmaceutics14030633","article-title":"Liposomal siRNA formulations for the treatment of herpes simplex virus-1: in vitro characterization of physicochemical properties and activity, and in vivo biodistribution and toxicity studies","volume":"14","author":"Jbara-Agbaria","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.chemphyslip.2026.105574_bib51","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.2147\/IJN.S391462","article-title":"Antiviral lipid nanocarrier loaded with remdesivir effective against SARS-CoV-2 in vitro model","author":"Jeon","year":"2023","journal-title":"Int. J. Nanomed."},{"issue":"4","key":"10.1016\/j.chemphyslip.2026.105574_bib52","first-page":"483","article-title":"Effect of liposome composition and cholesterol on the cellular uptake of stavudine by human monocyte\/macrophages","volume":"5","author":"Katragadda","year":"2000","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"10","key":"10.1016\/j.chemphyslip.2026.105574_bib53","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1080\/10611860802475688","article-title":"Lymphatic targeting of zidovudine using surface-engineered liposomes","volume":"16","author":"Kaur","year":"2008","journal-title":"J. Drug Target."},{"key":"10.1016\/j.chemphyslip.2026.105574_bib54","doi-asserted-by":"crossref","DOI":"10.1177\/20587384211002621","article-title":"A review: mechanism of action of antiviral drugs","volume":"35","author":"Kausar","year":"2021","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.chemphyslip.2026.105574_bib55","first-page":"1","article-title":"Development of molnupiravir and peramivir loaded liposome formulations for combined antiviral therapy","author":"Keskin","year":"2025","journal-title":"Pharm. Dev. Technol."},{"issue":"9","key":"10.1016\/j.chemphyslip.2026.105574_bib56","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.3390\/pharmaceutics14091886","article-title":"Review on the scale-up methods for the preparation of solid lipid nanoparticles","volume":"14","author":"Khairnar","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.chemphyslip.2026.105574_bib57","first-page":"2733","article-title":"Advanced drug delivery to the lymphatic system: lipid-based nanoformulations","author":"Khan","year":"2013","journal-title":"Int. J. Nanomed."},{"issue":"3","key":"10.1016\/j.chemphyslip.2026.105574_bib58","doi-asserted-by":"crossref","first-page":"446","DOI":"10.34172\/apb.2023.056","article-title":"An overview of nanostructured lipid carriers and its application in drug delivery through different routes","volume":"13","author":"Khan","year":"2022","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.chemphyslip.2026.105574_bib59","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jcis.2025.02.034","article-title":"Scalable production of uniform gene-loaded lipid nanoparticles via a fluidity-controlled membrane extrusion","volume":"687","author":"Kim","year":"2025","journal-title":"J. Colloid Interface Sci."},{"issue":"5","key":"10.1016\/j.chemphyslip.2026.105574_bib60","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2174\/2211738507666190829161737","article-title":"Effect of acyclovir solid lipid nanoparticles for the treatment of herpes simplex virus (HSV) infection in an animal model of HSV-1 infection","volume":"7","author":"Kondel","year":"2019","journal-title":"Pharm. Nanotechnol."},{"issue":"6","key":"10.1016\/j.chemphyslip.2026.105574_bib61","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/lipd.12269","article-title":"Lipid composition of liposomal membrane largely affects its transport and uptake through small intestinal epithelial cell models","volume":"55","author":"Konishi","year":"2020","journal-title":"Lipids"},{"issue":"2","key":"10.1016\/j.chemphyslip.2026.105574_bib62","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3390\/pharmaceutics17020276","article-title":"Navigating the clinical landscape of liposomal therapeutics in cancer treatment","volume":"17","author":"Kozak","year":"2025","journal-title":"Pharmaceutics"},{"issue":"45","key":"10.1016\/j.chemphyslip.2026.105574_bib63","doi-asserted-by":"crossref","first-page":"21733","DOI":"10.1039\/C9NR09347H","article-title":"On the role of helper lipids in lipid nanoparticle formulations of siRNA","volume":"11","author":"Kulkarni","year":"2019","journal-title":"Nanoscale"},{"issue":"3","key":"10.1016\/j.chemphyslip.2026.105574_bib64","doi-asserted-by":"crossref","first-page":"268","DOI":"10.2174\/1389201024666230523114350","article-title":"Lipid nanocapsule: a novel approach to drug delivery system formulation development","volume":"25","author":"Kumar","year":"2024","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"1","key":"10.1016\/j.chemphyslip.2026.105574_bib65","doi-asserted-by":"crossref","first-page":"13990","DOI":"10.1038\/s41598-018-32033-w","article-title":"Lipid-coated mesoporous silica nanoparticles for the delivery of the ML336 antiviral to inhibit encephalitic alphavirus infection","volume":"8","author":"LaBauve","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.chemphyslip.2026.105574_bib66","doi-asserted-by":"crossref","first-page":"6873","DOI":"10.1038\/s41598-023-33092-4","article-title":"Lipid-coated mesoporous silica nanoparticles for anti-viral applications via delivery of CRISPR-Cas9 ribonucleoproteins","volume":"13","author":"LaBauve","year":"2023","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.chemphyslip.2026.105574_bib67","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.cclet.2021.01.001","article-title":"STING-activating drug delivery systems: design strategies and biomedical applications","volume":"32","author":"Li","year":"2021","journal-title":"Chin. Chem. Lett."},{"issue":"4","key":"10.1016\/j.chemphyslip.2026.105574_bib68","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.3390\/molecules27041372","article-title":"A review of liposomes as a drug delivery system: current status of approved products, regulatory environments, and future perspectives","volume":"27","author":"Liu","year":"2022","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.chemphyslip.2026.105574_bib69","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3390\/foods14060973","article-title":"Lipid nanoparticles: formulation, production methods and characterization protocols","volume":"14","author":"L\u00fcdtke","year":"2025","journal-title":"Foods"},{"issue":"3","key":"10.1016\/j.chemphyslip.2026.105574_bib70","doi-asserted-by":"crossref","first-page":"418","DOI":"10.34172\/PS.2020.96","article-title":"Efavirenz loaded nanostructured lipid carriers for efficient and prolonged viral inhibition in HIV-infected macrophages","volume":"27","author":"Mahajan","year":"2020","journal-title":"Pharm. Sci."},{"issue":"1","key":"10.1016\/j.chemphyslip.2026.105574_bib71","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s13346-019-00670-x","article-title":"Shape mediated splenotropic delivery of buparvaquone loaded solid lipid nanoparticles","volume":"10","author":"Maithania","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.chemphyslip.2026.105574_bib72","article-title":"Nanostructured lipid carriers as a drug delivery system: a comprehensive review with therapeutic applications","author":"Mall","year":"2024","journal-title":"Intell. Pharm."},{"issue":"8","key":"10.1016\/j.chemphyslip.2026.105574_bib73","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1080\/17425247.2018.1503249","article-title":"Targeting the intestinal lymphatic system: a versatile path for enhanced oral bioavailability of drugs","volume":"15","author":"Managuli","year":"2018","journal-title":"Expert Opin. Drug Deliv."},{"issue":"9","key":"10.1016\/j.chemphyslip.2026.105574_bib74","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.3390\/ijms21093248","article-title":"Lipids and lipid-processing pathways in drug delivery and therapeutics","volume":"21","author":"Markovic","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.chemphyslip.2026.105574_bib75","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd1331","article-title":"Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes","volume":"3","author":"Matthews","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.chemphyslip.2026.105574_bib76","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1039\/D3LC00821E","article-title":"Microfluidic synthesis of lipid-based nanoparticles for drug delivery: recent advances and opportunities","volume":"24","author":"Mehraji","year":"2024","journal-title":"Lab Chip"},{"issue":"6","key":"10.1016\/j.chemphyslip.2026.105574_bib77","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1021\/acsmaterialsau.3c00032","article-title":"Lipid-based nanoparticles for drug\/gene delivery: an overview of the production techniques and difficulties encountered in their industrial development","volume":"3","author":"Mehta","year":"2023","journal-title":"ACS Mater. Au"},{"issue":"24","key":"10.1016\/j.chemphyslip.2026.105574_bib78","doi-asserted-by":"crossref","first-page":"9207","DOI":"10.1039\/c3cs60198f","article-title":"Cellular nanotechnology: making biological interfaces smarter","volume":"42","author":"Mendes","year":"2013","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.chemphyslip.2026.105574_bib79","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jconrel.2025.01.044","article-title":"Intranasal liposomal remdesivir induces SARS-CoV-2 clearance in K18-hACE2 mice and ensures survival","volume":"379","author":"Mendes","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.chemphyslip.2026.105574_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fddev.2023.1232012","article-title":"Lipid-based oral formulation in capsules to improve the delivery of poorly water-soluble drugs","volume":"3","author":"Mohite","year":"2023","journal-title":"Front. Drug Deliv."},{"issue":"1","key":"10.1016\/j.chemphyslip.2026.105574_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4236\/wjnse.2024.141001","article-title":"Leveraging nanotechnology for addressing COVID-19: revealing antiviral approaches and hurdles","volume":"14","author":"Mostafavi","year":"2024","journal-title":"World J. Nano Sci. Eng."},{"key":"10.1016\/j.chemphyslip.2026.105574_bib82","series-title":"Percutaneous penetration enhancers chemical methods in penetration enhancement: Nanocarriers","first-page":"161","article-title":"Nanostructured lipid carriers (NLC): the second generation of solid lipid nanoparticles","author":"M\u00fcller","year":"2016"},{"key":"10.1016\/j.chemphyslip.2026.105574_bib83","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/S0169-409X(02)00118-7","article-title":"Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations","volume":"54","author":"M\u00fcller","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.chemphyslip.2026.105574_bib84","first-page":"44","article-title":"Integrative medicine in the treatment of COVID-19: an Indian perspective","volume":"9","author":"Namdeo","year":"2023","journal-title":"Curr. Tradit. Med."},{"key":"10.1016\/j.chemphyslip.2026.105574_bib85","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jcis.2015.10.057","article-title":"Cellular uptake and transcytosis of lipid-based nanoparticles across the intestinal barrier: relevance for oral drug delivery","volume":"463","author":"Neves","year":"2016","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.chemphyslip.2026.105574_bib86","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijsu.2020.04.018","article-title":"The socio-economic implications of the coronavirus pandemic (COVID-19): A review","volume":"78","author":"Nicola","year":"2020","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.chemphyslip.2026.105574_bib87","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.addr.2016.04.001","article-title":"Lipid-based nanocarriers for oral peptide delivery","volume":"106","author":"Niu","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.chemphyslip.2026.105574_bib88","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.actbio.2020.07.027","article-title":"Engineering of monosized lipid-coated mesoporous silica nanoparticles for CRISPR delivery","volume":"114","author":"Noureddine","year":"2020","journal-title":"Acta Biomater."},{"issue":"5","key":"10.1016\/j.chemphyslip.2026.105574_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09394","article-title":"Liposomes: structure, composition, types, and clinical applications","volume":"8","author":"Nsairat","year":"2022","journal-title":"Heliyon"},{"issue":"9","key":"10.1016\/j.chemphyslip.2026.105574_bib90","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.3390\/pharmaceutics14091940","article-title":"Microfluidic manufacture of lipid-based nanomedicines","volume":"14","author":"Osouli-Bostanabad","year":"2022","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.chemphyslip.2026.105574_bib91","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0005-2736(97)00122-3","article-title":"Lymphatic uptake and biodistribution of liposomes after subcutaneous injection.: II. Influence of liposomal size, lipid composition and lipid dose","volume":"1328","author":"Oussoren","year":"1997","journal-title":"Biochim. Biophys. Acta (BBA)Biomembr."},{"issue":"33","key":"10.1016\/j.chemphyslip.2026.105574_bib92","doi-asserted-by":"crossref","first-page":"35223","DOI":"10.1021\/acsomega.4c01774","article-title":"Current overview on the use of nanosized drug delivery systems in the treatment of neurodegenerative diseases","volume":"9","author":"Ozceylan","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.chemphyslip.2026.105574_bib93","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.addr.2013.12.008","article-title":"Liposomal siRNA nanocarriers for cancer therapy","volume":"66","author":"Ozpolat","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.chemphyslip.2026.105574_bib94","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.nano.2008.08.003","article-title":"Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery","volume":"5","author":"Paliwal","year":"2009","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"43","key":"10.1016\/j.chemphyslip.2026.105574_bib95","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202401990","article-title":"A review: surface engineering of lipid-based drug delivery systems","volume":"20","author":"Patel","year":"2024","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.chemphyslip.2026.105574_bib96","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13578-023-01108-1","article-title":"A novel recombinant ORF7-siRNA delivered by flexible nano-liposomes inhibits varicella zoster virus infection","volume":"13","author":"Pei","year":"2023","journal-title":"Cell Biosci."},{"issue":"24","key":"10.1016\/j.chemphyslip.2026.105574_bib97","doi-asserted-by":"crossref","first-page":"15909","DOI":"10.3390\/ijms232415909","article-title":"Development of inhalable chitosan-coated oxymatrine liposomes to alleviate RSV-infected mice","volume":"23","author":"Peng","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.chemphyslip.2026.105574_bib98","doi-asserted-by":"crossref","unstructured":"N.C. Phillips and C. Tsoukas, Liposomal encapsulation of azidothymidine results in decreased hematopoietic toxicity and enhanced activity against murine acquired immunodeficiency syndrome, 1992.","DOI":"10.1182\/blood.V79.5.1137.1137"},{"key":"10.1016\/j.chemphyslip.2026.105574_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2021.102361","article-title":"Physico-chemical and physiological determinants of lipo-nanoparticle stability","volume":"33","author":"Pownall","year":"2021","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"1","key":"10.1016\/j.chemphyslip.2026.105574_bib100","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1208\/s12249-020-01908-5","article-title":"Recent advancement in nanotechnology-based drug delivery system against viral infections","volume":"22","author":"Pradhan","year":"2021","journal-title":"Aaps Pharmscitech"},{"key":"10.1016\/j.chemphyslip.2026.105574_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114197","article-title":"Microfluidic fabrication of lipid nanoparticles for the delivery of nucleic acids","volume":"184","author":"Prakash","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.chemphyslip.2026.105574_bib102","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1423-0127-17-57","article-title":"Development of a liposomal nanodelivery system for nevirapine","volume":"17","author":"Ramana","year":"2010","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.chemphyslip.2026.105574_bib103","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/B978-0-12-814031-4.00003-9","article-title":"Lipid-based nanoparticles for drug delivery systems","author":"Samimi","year":"2019","journal-title":"Charact. Biol. Nanomater. Drug Deliv."},{"key":"10.1016\/j.chemphyslip.2026.105574_bib104","article-title":"Formulation design, optimization, and evaluation of solid lipid nanoparticles loaded with an antiviral drug tenofovir using Box\u2013Behnken design for boosting oral bioavailability","volume":"2024","author":"Sangeetha","year":"2024","journal-title":"Adv. Pharmacol. Pharm. Sci."},{"key":"10.1016\/j.chemphyslip.2026.105574_bib105","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.587997","article-title":"Solid lipid nanoparticles for drug delivery: pharmacological and biopharmaceutical aspects","volume":"7","author":"Scioli Montoto","year":"2020","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"10.1016\/j.chemphyslip.2026.105574_bib106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.61797\/ijanca.v4i1.418","article-title":"Innovations and mechanisms in liposomal drug delivery: a comprehensive introduction","volume":"4","author":"Sengar","year":"2025","journal-title":"Int. J. Adv. Nano Comput. Anal."},{"key":"10.1016\/j.chemphyslip.2026.105574_bib107","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fphar.2015.00286","article-title":"Advances and challenges of liposome assisted drug delivery","volume":"6","author":"Sercombe","year":"2015","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.chemphyslip.2026.105574_bib108","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1080\/17425247.2016.1182492","article-title":"Exploitation of lipid-polymeric matrices at nanoscale for drug delivery applications","volume":"13","author":"Sgorla","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"issue":"8","key":"10.1016\/j.chemphyslip.2026.105574_bib109","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3390\/pharmaceutics13081312","article-title":"Nanostructured lipid carriers (NLCs) for oral peptide drug delivery: about the impact of surface decoration","volume":"13","author":"Shahzadi","year":"2021","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.chemphyslip.2026.105574_bib110","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2174\/156720108785915087","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers-innovative generations of solid lipid carriers","volume":"5","author":"Shidhaye","year":"2008","journal-title":"Curr. Drug Deliv."},{"issue":"1","key":"10.1016\/j.chemphyslip.2026.105574_bib111","article-title":"Lipid-based drug delivery systems","volume":"2014","author":"Shrestha","year":"2014","journal-title":"J. Pharm."},{"issue":"1","key":"10.1016\/j.chemphyslip.2026.105574_bib112","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.colsurfb.2011.03.035","article-title":"Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): high pressure homogenization versus ultrasound","volume":"86","author":"Silva","year":"2011","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"4","key":"10.1016\/j.chemphyslip.2026.105574_bib113","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.3390\/biomedicines11041114","article-title":"Cubosomes in drug delivery\u2014a comprehensive review on its structural components, preparation techniques and therapeutic applications","volume":"11","author":"Sivadasan","year":"2023","journal-title":"Biomedicines"},{"issue":"7","key":"10.1016\/j.chemphyslip.2026.105574_bib114","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3390\/pharmaceutics17070885","article-title":"Advances in liposomal drug delivery: multidirectional perspectives on overcoming biological barriers","volume":"17","author":"Sobol","year":"2025","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.chemphyslip.2026.105574_bib115","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/1061186X.2012.712130","article-title":"Nanoparticles-mediated drug delivery approaches for cancer targeting: a review","volume":"21","author":"Sultana","year":"2013","journal-title":"J. Drug Target."},{"key":"10.1016\/j.chemphyslip.2026.105574_bib116","first-page":"31","article-title":"Engineered nanoparticles for drug delivery in cancer therapy","author":"Sun","year":"2021","journal-title":"Nanomater. Neoplasms"},{"issue":"4","key":"10.1016\/j.chemphyslip.2026.105574_bib117","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3390\/vaccines9040359","article-title":"Lipid-based nanoparticles in the clinic and clinical trials: from cancer nanomedicine to COVID-19 vaccines","volume":"9","author":"Thi","year":"2021","journal-title":"Vaccines"},{"issue":"4","key":"10.1016\/j.chemphyslip.2026.105574_bib118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13577-025-01245-4","article-title":"Human metapneumovirus: a mini-review on the genetic and phylogenetic roots of a rising respiratory threat","volume":"38","author":"Tiwary","year":"2025","journal-title":"Hum. Cell"},{"key":"10.1016\/j.chemphyslip.2026.105574_bib119","doi-asserted-by":"crossref","DOI":"10.1039\/D5PM00109A","article-title":"Solid lipid nanoparticles in cervical cancer: a comprehensive review of a decade of progress and prospects","author":"Tiwary","year":"2025","journal-title":"RSC Pharm."},{"key":"10.1016\/j.chemphyslip.2026.105574_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemphyslip.2025.105510","article-title":"Solid lipid nanoparticles in the diagnosis and treatment of prostate cancer: a comprehensive review of two decades of advancements","author":"Tiwary","year":"2025","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.chemphyslip.2026.105574_bib121","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.colsurfb.2016.07.026","article-title":"Silencing of hepatitis C virus replication by a non-viral vector based on solid lipid nanoparticles containing a shRNA targeted to the internal ribosome entry site (IRES)","volume":"146","author":"Torrecilla","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"6","key":"10.1016\/j.chemphyslip.2026.105574_bib122","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.addr.2007.09.007","article-title":"Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update","volume":"60","author":"Trevaskis","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"10","key":"10.1016\/j.chemphyslip.2026.105574_bib123","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3390\/ph14101059","article-title":"Physicochemical characteristics and in vitro toxicity\/anti-SARS-CoV-2 activity of favipiravir solid lipid nanoparticles (SLNs)","volume":"14","author":"Tulbah","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/j.chemphyslip.2026.105574_bib124","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1007\/s13577-023-00903-9","article-title":"Global threat from novel SARS-CoV-2 variants, BF. 7, XBB. 1.5, BQ. 1, and BQ. 1.1: variants of concern?","volume":"36","author":"Varghese","year":"2023","journal-title":"Hum. Cell"},{"issue":"1","key":"10.1016\/j.chemphyslip.2026.105574_bib125","article-title":"Co-infections and immune-evading viral hybrids: A perspective","volume":"7","author":"Varghese","year":"2024","journal-title":"Heal. Sci. Rep."},{"issue":"5","key":"10.1016\/j.chemphyslip.2026.105574_bib126","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28829","article-title":"SARS-CoV-2 XBB. 1.16 variant: India in focus?","volume":"95","author":"Varghese","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.chemphyslip.2026.105574_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.colcom.2021.100561","article-title":"Cubosomes in cancer drug delivery: a review","volume":"46","author":"Varghese","year":"2022","journal-title":"Colloid Interface Sci. Commun."},{"issue":"2","key":"10.1016\/j.chemphyslip.2026.105574_bib128","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/MS9.0000000000001627","article-title":"An impending public health threat: analysis of the recent Nipah virus outbreak and future recommendations\u2013an editorial","volume":"86","author":"Verma","year":"2024","journal-title":"Ann. Med. Surg."},{"issue":"6","key":"10.1016\/j.chemphyslip.2026.105574_bib129","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.3390\/pharmaceutics15061593","article-title":"Solid lipid nanoparticles vs. nanostructured lipid carriers: a comparative review","volume":"15","author":"Viegas","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.chemphyslip.2026.105574_bib130","article-title":"An insight on lipid nanoparticles for therapeutic proteins delivery","volume":"77","author":"Viegas","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"2","key":"10.1016\/j.chemphyslip.2026.105574_bib131","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1208\/s12249-019-1293-3","article-title":"Lipid-based nanocarriers for lymphatic transportation","volume":"20","author":"Vishwakarma","year":"2019","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"10.1016\/j.chemphyslip.2026.105574_bib132","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.3390\/pharmaceutics15041053","article-title":"Use of microfluidics to prepare lipid-based nanocarriers","volume":"15","author":"Vogelaar","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.chemphyslip.2026.105574_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115130","article-title":"Nanocarriers transport across the gastrointestinal barriers: the contribution to oral bioavailability via blood circulation and lymphatic pathway","volume":"203","author":"Wang","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.chemphyslip.2026.105574_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119266","article-title":"Using microfluidics for scalable manufacturing of nanomedicines from bench to GMP: a case study using protein-loaded liposomes","volume":"582","author":"Webb","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.chemphyslip.2026.105574_bib135","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s44337-024-00121-8","article-title":"Enhancing antiretroviral efficacy: a comprehensive exploration of liposomal and receptor-targeted drug delivery for HIV","volume":"1","author":"Woldu","year":"2024","journal-title":"Discov. Med."},{"issue":"1\u20132","key":"10.1016\/j.chemphyslip.2026.105574_bib136","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ijpharm.2017.02.015","article-title":"Lipid nanovehicles with adjustable surface properties for overcoming multiple barriers simultaneously in oral administration","volume":"520","author":"Wu","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.chemphyslip.2026.105574_bib137","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1039\/D3NR05083A","article-title":"Digestion of lipid micelles leads to increased membrane permeability","volume":"16","author":"Xie","year":"2024","journal-title":"Nanoscale"},{"issue":"2","key":"10.1016\/j.chemphyslip.2026.105574_bib138","doi-asserted-by":"crossref","DOI":"10.1002\/anbr.202100109","article-title":"Lipid nanoparticles for drug delivery","volume":"2","author":"Xu","year":"2022","journal-title":"Adv. NanoBiomed Res."},{"issue":"10\u201311","key":"10.1016\/j.chemphyslip.2026.105574_bib139","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.addr.2011.05.019","article-title":"Intestinal lymphatic transport for drug delivery","volume":"63","author":"Y\u00e1\u00f1ez","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.chemphyslip.2026.105574_bib140","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.cclet.2021.01.014","article-title":"Nanomaterials toward the treatment of Alzheimer\u2019s disease: Recent advances and future trends","volume":"32","author":"Zeng","year":"2021","journal-title":"Chin. Chem. Lett."},{"issue":"1","key":"10.1016\/j.chemphyslip.2026.105574_bib141","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12016-022-08921-5","article-title":"Risk and protective factors for COVID-19 morbidity, severity, and mortality","volume":"64","author":"Zhang","year":"2023","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"3","key":"10.1016\/j.chemphyslip.2026.105574_bib142","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3390\/v15030647","article-title":"Advances in antiviral delivery systems and chitosan-based polymeric and nanoparticulate antivirals and antiviral carriers","volume":"15","author":"\u017digrayov\u00e1","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.chemphyslip.2026.105574_bib143","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejpb.2022.05.003","article-title":"Digestion of lipid excipients and lipid-based nanocarriers by pancreatic lipase and pancreatin","volume":"176","author":"Z\u00f6ller","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."}],"container-title":["Chemistry and Physics of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009308426000101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009308426000101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T13:59:20Z","timestamp":1775311160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009308426000101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":143,"alternative-id":["S0009308426000101"],"URL":"https:\/\/doi.org\/10.1016\/j.chemphyslip.2026.105574","relation":{},"ISSN":["0009-3084"],"issn-type":[{"value":"0009-3084","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid-based nanocarriers for antiviral drug delivery: A review of the advances, manufacturing technologies, therapeutic mechanisms, and clinical applications","name":"articletitle","label":"Article Title"},{"value":"Chemistry and Physics of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chemphyslip.2026.105574","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105574"}}